Skip to content

Clinical trials

Phase 2 Hypothyroidism trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypothyroidism Phase: Phase 2 Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20132
20181
20191
20202
20221
20233
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Not yet recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)2
Allergan1
Cairo University1
Dr Adnan Agha1
Ipe, LLC1
Neuvosyn Laboratories, LLC1
Oslo University Hospital1
Sention Therapeutics, LLC1
Takeda1
University of Pennsylvania1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypothyroidism13
Thyroid Diseases2
Thyroid Neoplasms2
Ascorbic Acid Deficiency1
Endocrine System Diseases1
Goiter1
Hyperthyroidism1
Menstruation Disturbances1
Pituitary Diseases1
Pituitary Neoplasms1

Trials

Showing 76 to 13 of 13. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.